Vitamin D priming may also serve as a potential adjunct to PDAC therapy given that the vitamin D receptor is expressed in the stroma of human pancreatic tumors and is involved in stromal remodeling and increased intratumoral drug delivery that may result in tumor volume reduction in combination strategies [67]. Here, VDR is linked to neoplasm.